What Are Grey Market Peptides? Risks and What the New HHS Policy Changes
By Kevin Jones, MD · Last updated November 2026
Grey market peptides, also spelled gray market peptides, are peptides sold online outside regulated medical channels. Most carry a “research use only” or “not for human consumption” label. That label isn’t a safety statement, though. Instead, it lets sellers sidestep drug rules while you carry the risk. These products skip the purity testing, sterility standards, and dose checks that prescription peptides must pass.
The rules around peptides also just changed. On October 28, 2026, the U.S. Department of Health and Human Services (HHS) released a draft policy that opens a prescription path for six popular peptides. As a result, many patients now ask whether grey market vials are suddenly legal. The short answer is no. Below, we explain what the policy does, what it doesn’t do, and how to stay safe.
Quick answer (November 2026): The new HHS policy lets state-licensed 503A pharmacies compound BPC-157, TB-500, epitalon, MOTS-c, KPV, and semax with a prescription, under strict conditions. It does not make these peptides FDA-approved. It also gives no cover to websites selling “research use only” vials. In fact, HHS says the policy exists to pull patients away from those sellers.
Grey Market vs. Prescription Peptides: The Real Difference
Grey market peptides | Prescription / compounded peptides | |
|---|---|---|
How it’s sold | Online, no prescription, “research use only” label | By prescription, through a licensed pharmacy |
Who makes it | Often unregistered labs, frequently overseas | Licensed 503A compounding pharmacies, regulated by state boards |
Purity testing | Rare; batch COAs often missing, unverifiable, or falsified | Required; batch-tested for potency and impurities |
Sterility | No guarantee | Prepared under sterile compounding standards |
Dosing accuracy | Unverified; contents may differ from the label | Verified concentration |
Medical oversight | None; you are self-prescribing | Evaluation, dosing, monitoring, follow-up |
If something goes wrong | No recourse | A licensed provider is accountable |
Under the 2026 HHS policy | Not covered at all | Six peptides may be compounded under strict conditions |
Why It’s Called the “Grey” Market
It isn’t the black market. Nobody sells these out of a car trunk. Instead, grey market sellers work in the gap between legal prescribing and outright illegal sales.
The label is the trick. By marking a vial “research use only,” a seller claims to offer a lab chemical, not a drug. What you do with it then becomes your problem. In practice, however, these sellers market straight to consumers. Many also bundle syringes and bacteriostatic water and post dosing guides. That’s why the FDA now treats the label as a ruse rather than a shield.
Simply put, that label protects the seller. It doesn’t protect you.
What the New HHS Peptide Policy Says
On October 28, 2026, HHS published its Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances. HHS Secretary Robert F. Kennedy Jr. signed it.
“Enforcement discretion” sounds technical, but the meaning is simple. HHS won’t act against state-licensed pharmacies, federal facilities, or licensed physicians who compound six specific peptides, as long as they meet every condition. The six peptides are:
- BPC-157
- TB-500
- Epitalon
- MOTS-c
- KPV
- Semax
According to HHS, the goal is to discourage the widespread use of research-use-only peptides from foreign manufacturers. In other words, the federal government now names the grey market as the problem it wants to shrink.
The conditions compounders must meet
The policy isn’t a blank check. To qualify, a compounder must:
- Fill a valid, patient-specific prescription.
- Use only the identity and route of administration listed for each peptide in the policy’s appendix.
- Buy the raw ingredient from an FDA-registered, CGMP-compliant manufacturer, with a valid certificate of analysis (COA).
- Make single-ingredient products only, so no blends or “stacks.”
- Package injectables only with FDA 510(k)-cleared syringes.
- Keep proof that any oral version actually absorbs in humans.
- Report serious adverse events to the FDA’s MedWatch program.
- Label every product: “This is a compounded drug product. Not for resale.”
Notice how many of these rules target what grey market vials lack. Traceable sourcing, verified COAs, single ingredients, and safety reporting are all missing from a typical research-peptide order.
What the policy does not do
- It doesn’t make any of these peptides FDA-approved, and HHS says it doesn’t establish safety or effectiveness.
- It doesn’t add them to the 503A Bulks List; formal rulemaking still has to happen.
- It doesn’t cover 503B outsourcing facilities.
- It doesn’t cover other popular peptides, such as CJC-1295 or ipamorelin.
- It doesn’t protect research-use-only websites in any way.
Keep in mind that this is still a draft. Public comments close November 13, 2026, and HHS expects to issue a final version afterward. HHS also says it may revisit the policy if safety signals or quality problems appear.
How We Got Here: A Timeline of Peptide Regulation
Date | What happened |
|---|---|
September 2023 | FDA moves more than a dozen commonly compounded peptides into Category 2 (significant safety concerns). Licensed pharmacies stop compounding them, and demand shifts to the grey market. |
April 2026 | FDA removes twelve peptides from Category 2. They leave the prohibited list but don’t join the permitted one. |
July 23–24, 2026 | FDA’s Pharmacy Compounding Advisory Committee (PCAC) reviews seven peptides. FDA scientists recommend against all seven. Even so, the committee narrowly recommends six and rejects emideltide (DSIP). |
August 2026 | FDA sends warning letters to five online peptide sellers and rejects their “research use only” disclaimers. |
October 28, 2026 | HHS releases its draft enforcement-discretion policy for the six recommended peptides. |
November 13, 2026 | The public comment period on the draft policy closes. |
February 2027 (expected) | PCAC plans to review five more peptides. |
The through-line is simple. First, restricting the regulated supply in 2023 pushed patients toward unregulated sellers. Now, regulators want to pull them back with a regulated option while cracking down on online vendors.
Does the HHS Policy Make Grey Market Peptides Legal?
No. The policy covers licensed pharmacies filling prescriptions. It doesn’t cover websites selling vials.
Meanwhile, enforcement against those websites is rising, not falling. In August 2026, FDA sent warning letters to five online sellers after reviewing their sites. Those letters rejected “research use only” and “for laboratory use” disclaimers. They also treated bundled bacteriostatic water as a drug product. Around the same time, a federal criminal case ended in a felony conviction for a peptide company CEO who combined research-use-only marketing with fraud.
The science hasn’t changed, either. Before the July vote, FDA reviewers found human evidence thin or absent and safety data insufficient. They also flagged immune-reaction (immunogenicity) concerns for injectable use. A policy change doesn’t erase those gaps.
So if a website tells you BPC-157 is “legal now,” check what it actually sells. A vial with no prescription, no pharmacy label, and a research-only disclaimer is still a grey market product. For the broader legal picture, read our guide, Are Peptides Legal in the U.S.? [EDITOR: add live URL].
What Independent Testing Has Found in Grey Market Peptides
The core issue isn’t that every peptide is dangerous. Rather, it’s that you have no way to know what’s in the vial. Testing of unregulated peptide products has repeatedly turned up:
- Wrong dose. Much more or much less active ingredient than the label states.
- Impurities and breakdown byproducts from poor synthesis or poor storage.
- Bacterial contamination and endotoxins, a serious concern for anything you inject.
- The wrong compound entirely, or a different peptide than advertised.
- Unreliable COAs. Some sellers provide none. Others provide certificates that don’t match your batch or an accredited lab, and some are simply fake.
Peptides act on hormone, inflammation, and tissue-repair pathways. For that reason, small errors in what you inject are not small errors in effect.
Shipping adds a second problem. Even a peptide that left the lab intact can break down in a hot mailbox. Prescription peptides move through a cold chain, whereas a package from an overseas seller usually doesn’t.
“But Everyone Online Says They’re Fine”
Here are honest answers to the arguments you’ll see in forums.
“It’s legal now, so my vial is fine.” Not quite. The new policy covers pharmacy-compounded products made from FDA-registered sources. Your research vial didn’t come from that system, so the policy changes nothing about what’s inside it.
“It’s the same molecule.” Maybe, but you can’t verify that. Two vials with the same name on the sticker only match if both were made to the same standard, tested by an accredited lab, and stored correctly.
“Doctors just want to gatekeep.” Medical oversight isn’t a toll booth. It means screening for conditions and medications that make a peptide a bad idea for you, choosing the right dose, and catching problems early.
“There’s tons of research on recovery peptides.” Most of it is animal research. Rigorous human trials are largely missing, which is exactly what FDA’s reviewers concluded this year.
“It’s way cheaper.” That’s true, and cost is a real concern because insurance rarely covers peptide therapy. Still, the savings come from skipping the steps that make a product safe.
What About Grey Market GLP-1s and Retatrutide?
The same sellers often offer GLP-1 medications too, including semaglutide, tirzepatide, and retatrutide. Several of the August 2026 FDA warning letters cited exactly these “research” GLP-1 products.
Retatrutide deserves a specific warning. It’s still investigational and not FDA-approved. Eli Lilly has said it plans to file for FDA approval in early 2027, and the HHS peptide policy doesn’t include it. Therefore, every vial sold online today is an unapproved compound from an unregulated source. Learn more in our post on why we aren’t prescribing retatrutide yet [EDITOR: add live URL].
For semaglutide and tirzepatide, you have legitimate options. These include FDA-approved brands and, where legally permitted, compounded versions. Our GLP-1 medical weight loss program works through licensed pharmacies, with a real prescription and real follow-up.
How to Spot a Grey Market Peptide Seller
Watch for these red flags before you buy anything:
- No prescription or medical visit is required.
- The label says “research use only” or “not for human consumption.”
- The site sells bacteriostatic water and syringes alongside the peptide.
- Dosing charts or “protocols” appear next to a research-only disclaimer.
- The COA is generic, undated, or doesn’t match your batch number.
- The product ships from overseas with no cold-chain packaging.
- The listing offers peptide blends; the HHS policy allows single-ingredient products only.
- Prices sit far below any licensed pharmacy.
If you see even one of these signs, walk away. Our post Don’t Risk It [EDITOR: add live URL] covers more warning signs for online GLP-1 and peptide sources.
How Flow Wellness Approaches Peptides
We don’t prescribe, recommend, or support grey market peptides. Here’s what we do instead:
- Certified 503A compounding pharmacies only. No research-grade product and no reconstitute-it-yourself kits.
- A clinical evaluation first. The question is whether a peptide suits you, not just whether you can get it.
- Verified dosing and concentration, so you know exactly what you inject.
- Lab and body composition monitoring at our Bend and Seattle clinics to track how your body responds.
- Honest answers as the rules change. As the HHS policy becomes final, we’re reviewing which of the six peptides, if any, we can prescribe responsibly through a qualifying pharmacy. When a peptide isn’t appropriate or available, we’ll tell you. [EDITOR: Dr. Jones to confirm Flow’s position on the six peptides before publishing.]
We know that last point can cost us business. Even so, it’s the right answer.
If you’re weighing peptide therapy, we’d rather walk you through the real options than watch you order a vial online. Book a consultation at our clinics in Bend, Oregon or Seattle, Washington, or by telehealth across California, Oregon, and Washington. You can also read how peptides differ from steroids.
Written and medically reviewed by Dr. Kevin Jones, MD, Board-Certified in Emergency Medicine and Obesity Medicine. Medical Director, Flow Wellness. Last updated: November 2026.
FAQs
What are grey market peptides?
Grey market peptides are peptides sold online outside regulated medical channels, usually labeled “research use only” or “not for human consumption.” Sellers offer them without a prescription or medical oversight. They also skip the purity, sterility, and dosing checks that prescription peptides must pass.
Is it “grey market” or “gray market” peptides?
Both spellings mean the same thing. “Gray” is the standard American spelling, while “grey” is British. In peptide discussions, people use them interchangeably.
What did HHS change about peptides in 2026?
On October 28, 2026, HHS released a draft enforcement-discretion policy. It says HHS won’t take action against state-licensed 503A pharmacies, federal facilities, or licensed physicians that compound six specific peptides with a prescription, as long as they meet strict sourcing, labeling, and safety-reporting conditions.
Which peptides does the HHS policy cover?
The draft policy covers six peptides: BPC-157, TB-500, epitalon, MOTS-c, KPV, and semax. These are the same six that FDA’s advisory committee recommended in July 2026. Emideltide (DSIP) and popular peptides such as CJC-1295 and ipamorelin are not included.
Does the HHS policy make grey market peptides legal?
No. The policy applies only to licensed pharmacies filling patient-specific prescriptions from FDA-registered ingredient sources. It does not protect websites selling research-use-only vials. In fact, HHS says the policy aims to steer patients away from those sellers.
Is BPC-157 FDA-approved now?
No. BPC-157 is not FDA-approved for any condition. Under the draft HHS policy, a licensed 503A pharmacy may compound it with a prescription. However, HHS states the policy does not establish that BPC-157 is safe or effective.
Are grey market peptides safe?
They carry real, avoidable risks. Independent testing has found wrong doses, impurities, bacterial contamination, and even the wrong compound. Because there’s no verified COA, no sterility guarantee, and no medical oversight, you can’t reliably know what you’re injecting.
Why are grey market peptides labeled “research use only”?
The label lets sellers try to avoid the rules for drugs meant for people and shifts responsibility to the buyer. However, the FDA has repeatedly rejected that disclaimer when a seller’s marketing, dosing guides, or bundled syringes show the product is meant for human use.
What is the difference between grey market and compounded peptides?
Compounded peptides come from licensed 503A pharmacies with a valid prescription and state board oversight. Grey market peptides come from unregulated sellers with no verifiable quality control. Compounded doesn’t mean FDA-approved, but it does mean regulated, tested, and prescribed.
Is retatrutide available by prescription?
No. Retatrutide is still investigational and not FDA-approved. Eli Lilly has said it plans to file for FDA approval in early 2027, and the HHS peptide policy doesn’t cover it. Any retatrutide sold online today comes from an unregulated source.
I already used a grey market peptide. What should I do?
Stop using it and talk to a licensed medical provider. Bring the product and its labeling with you. If you have fever, an injection-site infection, unusual swelling, or anything else that worries you, seek medical care promptly. Your provider is there to help, not to judge.
References (bottom of post)
- U.S. Department of Health and Human Services. Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances. Federal Register, October 2026.
- U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee Meeting, July 23–24, 2026. [EDITOR: link the FDA advisory committee meeting page]
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. [EDITOR: keep the existing link from the current post]
Written and medically reviewed by Dr. Kevin Jones, MD, Board-Certified Emergency Medicine and Obesity Medicine
Medical Director, Flow Wellness
Last updated: July 2026
Frequently Asked Questions
What are grey market peptides?
Grey market peptides are peptides sold online outside regulated medical channels, typically labeled “research use only” or “not for human consumption.” They are sold without a prescription, without medical oversight, and without the purity, sterility, and dosing verification required of prescription peptides. The label allows sellers to avoid FDA regulation and legal liability.
Is it “grey market” or “gray market” peptides?
Both spellings refer to the same thing. “Gray” is the standard American spelling and “grey” the British one; in peptide discussions you’ll see them used interchangeably.
Are grey market peptides safe?
They carry real, avoidable risks. Independent testing has found unregulated peptide products with inaccurate dosing, impurities, bacterial contamination, and in some cases a different compound than advertised. Because there is no verified Certificate of Analysis, no sterility guarantee, and no medical oversight, there is no reliable way to know what you are injecting.
Are grey market peptides legal?
They occupy a legal grey zone — which is where the name comes from. Sellers avoid direct violation by labeling products “research use only,” but the products are widely marketed for and used in humans. Buying them is not the same as obtaining a lawfully prescribed, compounded peptide from a licensed pharmacy.
Why are grey market peptides labeled “research use only”?
The label lets the seller avoid the regulations that govern drugs intended for human use, and shifts legal responsibility to the buyer. It is a liability shield for the vendor, not a safety statement about the product.
Why do doctors warn against buying peptides online?
Because contamination, inaccurate dosing, degradation during shipping, and the absence of any medical screening or monitoring meaningfully increase the risk of harm — and if something goes wrong, there is no accountable party and no recourse.
Is retatrutide available by prescription?
No. Retatrutide is an investigational medication still in clinical trials and is not FDA-approved. It is not available through any legitimate U.S. prescription channel. Retatrutide sold online is an unapproved investigational compound from an unregulated source.
What is the difference between grey market and compounded peptides?
Compounded peptides are prepared by licensed 503(a) pharmacies against a valid prescription, under state pharmacy board oversight, with sterility and testing standards. Grey market peptides are sold without a prescription by unregulated sellers with no verifiable quality control. Compounded does not mean FDA-approved, but it does mean regulated, tested, and prescribed.
I already used a grey market peptide. What should I do?
Stop and talk to a licensed medical provider. Bring the product and any labeling with you. If you have symptoms such as fever, injection-site infection, unusual swelling, or anything that concerns you, seek medical care promptly. Providers are there to help you, not to judge you for what you’ve already taken.
References
- U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee Meeting, July 23–24, 2026.
- U.S. Food and Drug Administration. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
Related Peptide Resources

How Many Units Do I Draw Up for My Peptide?
Peptide Dosage Explained: How Many Units Should I Inject? Your dose is the amount of medication. The units are the amount of liquid needed to

Are Peptides Legal in the U.S.? (2026 Update: HHS Peptide Compounding Policy)
Allison Jones, FNP · Medically reviewed by Dr. Kevin Jones, MD Updated November 2026 to reflect the HHS enforcement discretion policy for six compounded peptides

Do I Really Have to Throw Away My Medicine After 28 Days?
Why You Should Discard Open Vials After 28 Days, Even If There’s Medicine Left If you’ve ever looked at your medication, whether it’s a multi-use
Disclaimer: This blog post is for informational purposes only and should not be considered medical advice. Always consult with a healthcare provider for personalized medical advice.